Obesity Rates Fall as Weight-Loss Drug Use Surges
Intermediate | November 5, 2025
✨ Read the article aloud on your own or repeat each paragraph after your tutor.
A Turning Point for Obesity Trends and Weight-Loss Drug Use
New 15-year data show that the adult obesity rate in the United States has dropped from about 39% to 37% as more people adopt advanced medications for weight control. (yahoo.com) At the same time, Weight-Loss Drug Use (such as GLP-1 medications like semaglutide and tirzepatide) has more than doubled in recent months. (people.com)
Why the Shift Matters
Experts say this decline is notable because adults’ body-mass index (BMI) categories had been steadily rising for decades. The surge in Weight-Loss Drug Use appears to correlate with this drop: one survey found that 12.4% of adults reported using weight-loss medications in 2025, up from 5.8% in early 2024. (people.com) These drugs suppress appetite and slow digestion, helping people lose significant weight when paired with lifestyle change.
Who’s Leading the Change
The biggest improvements occurred among adults aged 40–64, the same group showing the highest GLP-1 usage. In this age bracket, obesity rates dropped more sharply, which suggests a stronger effect or higher adoption of treatments. (people.com) Women reported slightly higher usage than men, and that may be part of why their obesity rates improved more in recent surveys.
Don’t Get Too Comfortable
Despite the positive news, several caveats apply. First, a reduction from 39% to 37% still leaves well over one in three U.S. adults classified as obese. Data rely on self-reported height and weight, which might under-estimate true levels. (people.com) Also, drug access remains uneven: insurance coverage is inconsistent, and costs may exceed US$500/month out of pocket if coverage is lacking. (gpb.org)
What This Means for Busy Professionals
From a business-English and professional-skills perspective, the story matters on two levels. First, it reflects how medical innovation and Weight-Loss Drug Use are reshaping established trends and how language around “weight-loss treatments,” “GLP-1s,” and “obesity rates” is becoming business-relevant. Second, for professionals in health, wellness, tech, or corporate wellness programs, it’s a signal that employee health dynamics are changing—and could influence benefits, productivity, or investor discussions.
Vocabulary
- Obesity (noun) – the condition of being significantly overweight, with a BMI of 30 or more.
Example: “Efforts to lower the national obesity rate have been ongoing for decades.” - Medication (noun) – a substance used for medical treatment.
Example: “New medications like GLP-1 drugs are changing weight-loss options.” - Correlate (verb) – to have a mutual relationship or connection.
Example: “The rise in drug use correlates with the drop in obesity rates.” - Adoption (noun) – the act of beginning to use something new.
Example: “Rapid adoption of GLP-1 medications surprised many analysts.” - Out-of-pocket (adj/adv) – paid directly by a person rather than via insurance.
Example: “Without coverage, patients may face out-of-pocket costs of five hundred dollars per month.” - Bracket (noun) – a range or category, often of age or income.
Example: “The 40–64 age bracket showed the largest obesity decline.” - Caveat (noun) – a warning or limitation.
Example: “There’s a caveat: self-reported data may understate true obesity levels.” - Innovation (noun) – a new method, idea, or product.
Example: “Medical innovation in weight-loss drugs is reshaping an old public-health problem.” - Productivity (noun) – the effectiveness of productive effort.
Example: “Employee health can impact productivity, making this trend relevant to corporate managers.” - Wellness (noun) – the state of being in good health, especially as an actively pursued goal.
Example: “Corporate wellness programs may now include access to new weight-loss treatments.”
Discussion Questions (About the Article)
- Why might the use of GLP-1 medications help reduce obesity rates?
- What are some of the limitations or caveats mentioned in the article?
- Why did the age bracket 40–64 show a stronger decline in obesity?
- How could out-of-pocket costs affect access to weight-loss medications?
- How might this trend affect employee wellness programs in companies?
Discussion Questions (About the Topic)
- In your country (Korea or Taiwan), do you see similar trends in obesity or weight-loss treatments?
- How important is language (like “GLP-1”, “medication adoption”) in business discussions about health?
- If you were a manager responsible for corporate wellness, how might this trend influence your strategy?
- How could understanding medical-health vocabulary benefit your professional English skills?
- Do you think the reduction in obesity rates is mainly due to medication, lifestyle change, or both?
Related Idiom
“Turn the tide” – to cause a change in a positive direction.
Example: “New medications may help turn the tide in the long-running fight against obesity.”
📢 Want more tips like this? 👉 Sign up for the All About English Mastery Newsletter! Click here to join us!
Want to finally Master English but don’t have the time? Mastering English for Busy Professionals shows you how to improve in just 10 minutes a day.
Follow our YouTube Channel @All_About_English for more great insights and tips.
This article was inspired by: Yahoo News – Obesity rates on decline in the last 15 years, meanwhile weight loss drug use on the rise (Oct 28, 2025)


